(IN BRIEF) Savills has appointed Joel Gazeres to its Operational Capital Markets (OCM) division, where he will focus on growing the Healthcare and Senior Living team. Gazeres joins from CBRE, bringing ...
(IN BRIEF) Solvay and Hankook have signed a Memorandum of Understanding (MOU) to develop circular silica derived from biosourced and waste materials for tire production. This collaboration leverages ...
(IN BRIEF) Solvay and Hankook have signed a Memorandum of Understanding (MOU) to develop circular silica derived from biosourced and waste materials for tire production. This collaboration leverages ...
(IN BRIEF) Sarclisa, an anti-CD38 treatment developed by Sanofi, has been approved in China for treating adult patients with relapsed or refractory multiple myeloma (R/R MM) who have received at least ...
(IN BRIEF) Sarclisa, an anti-CD38 treatment developed by Sanofi, has been approved in China for treating adult patients with relapsed or refractory multiple myeloma (R/R MM) who have received at least ...
(IN BRIEF) Sarclisa, an anti-CD38 treatment developed by Sanofi, has been approved in China for treating adult patients with relapsed or refractory multiple myeloma (R/R MM) who have received at least ...
(IN BRIEF) Sarclisa, an anti-CD38 treatment developed by Sanofi, has been approved in China for treating adult patients with relapsed or refractory multiple myeloma (R/R MM) who have received at least ...
University of Liverpool’s New Infrared Wand Shows Promise in Revolutionizing Oral Cancer Diagnosis
A prototype of the Liverpool Diagnostic Infrared Wand (LDIR Wand), developed by the University of Liverpool in collaboration with the Liverpool H ...
A prototype of the Liverpool Diagnostic Infrared Wand (LDIR Wand), developed by the University of Liverpool in collaboration with the Liverpool Head and Neck Cancer Centre, has shown promising results ...
A prototype of the Liverpool Diagnostic Infrared Wand (LDIR Wand), developed by the University of Liverpool in collaboration with the Liverpool Head and Neck Cancer Centre, has shown promising results ...
(IN BRIEF) A prototype of the Liverpool Diagnostic Infrared Wand (LDIR Wand), developed by the University of Liverpool in collaboration with the Liverpool Head and Neck Cancer Centre, has shown ...
(IN BRIEF) Sarclisa, an anti-CD38 treatment developed by Sanofi, has been approved in China for treating adult patients with relapsed or refractory multiple myeloma (R/R MM) who have received at least ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback